Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate + TNF Inhibitor in Ankylosing Spondylitis
NCT02313727Phase 4Unknown
- Sponsor
- Bnai Zion Medical Center
- Start
- Dec 2014
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of pamidronate in ankylosing spondylitis (AS), sponsored by Bnai Zion Medical Center. Status: unknown.
02
Drugs
pamidronate
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02313727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313727.